Audeara Ltd
Audeara Limited is a global hearing health company.
The business
Audeara Limited is a global hearing health company. The Company specializes in listening solutions for people with hearing challenges. Its principal activity is development of hearing health technology. Its headphones deliver personalized audio to users via Bluetooth headphones. Its headphones are categorized as an assistive listening device (ALD), which can be paired with its mobile application called the Audeara App. Its technology is compatible for use with cochlear implants and hearing aids. The Audeara App uses a personalized algorithm to calibrate the headphones for an individual’s hearing profile. This provides clear sound quality for video conferencing and telephone calls and using mainstream applications like watching television, listening to music, and gaming. Its products include A-01 Headphones, BT-01 Transceiver, A-02 Headphones and A-02 TV Bundle. It sells its products through distributors and resellers in Australia and North America, and via e-commerce channels.
Small Caps Research
No research on Audeara Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise AUA based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
Audeara Confirms First Commercial Chinese Order Under Eastech Licensing Agreement
Audeara (ASX: AUA) has received its first purchase order under its licensing agreement with Eastech (Huizhou), a wholly owned subsidiary of Eastech Holding Limited, marking its formal entry into the Chinese hearing aid market. The initial order for 1,000 hearing aid technology licence keys demonstrates early commercial traction for Audeara’s proprietary hearing technology in one of […]
Audeara strengthens Asian presence with Clinico healthy hearing earbuds contract
Advanced hearing technology provider Audeara (ASX: AUA) has received a $570,000 mass production purchase order for its healthy hearing earbuds from Taiwan’s largest hearing aid retailer, Clinico. The products will be sold exclusively in China and Taiwan under Clinico’s branding ahead of an official product launch scheduled for the second quarter of the 2025 financial […]
Picking the winners from the losers amid the ongoing IPO mania
Like climbers queuing below the Mt Everest summit before the next blizzard sets in, private vendors are continuing to join the initial public offer (IPO) conga line before the market turns foul. Or has the IPO weather turned already? Frankly, it’s hard to tell. In total 88 companies have already executed an IPO in calendar […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.